Injectable Drug Delivery Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type, Formulation, Formulation Packaging, End User, and Geography

Description

List of Tables

According to our new research study on "Injectable Drug Delivery Market Forecast to 2031 -Global Analysis - by Type, and End User," the market is anticipated to grow from US$ 40.56 billion in 2024 to US$ 70.84 billion by 2031; the market is expected to register a CAGR of 8.5% from 2025 to 2031. The injectable drug delivery market growth is attributed to the rising global burden of chronic diseases, surge in biologics and monoclonal antibodies requiring parenteral administration, and technological advancements in self-injection and patient-centric delivery devices.

The delivery of drugs via injection involves administering drugs through the use of needles or needle-free delivery devices directly into the patient's body. Injectables provide a quick, accurate, and consistent means of administering therapeutic agents to patients. Injectables are an important delivery method for biologics, vaccinations, insulin products, cancer chemotherapy agents, emergency medications, and other medications that cannot be delivered in oral or other traditional routes. AI-driven personalization, advancing lipid nanoparticle injectables for rapid-response vaccines and gene editing, and biodegradable polymers and green packaging in injectable drug systems are expected to be major injectable drug delivery market trends in the coming years.

The injectable drug delivery market in North America is segmented into the US, Canada, and Mexico. The North America injectable drug delivery market is expanding owing to several factors. The US holds the largest market share, followed by Canada. The collaborative innovation in sterile filling and finishing of product components between many of the pharmaceutical companies in order to establish complex biological products like the GLP-1 therapies will be the main focus of this section. In addition, multi-national companies, such as Roche/Genentech and Novartis, have established strategic partnerships with their B2B partners to create subcutaneous delivery systems (self-injectable formats) for oncology drugs (Avastin, Rituxan) that are more user-friendly than intravenous routes, which limit patient compliance, while at the same time increasing the bioavailability of the drug to the patient, allowing them to administer the product at home. This synergy within the healthcare industry provides an efficient process for managing product life-cycles and reduces the burden on the healthcare system by focusing on the user-friendly designs of these products. An example of disruptive technology is Enable Injections' wearable devices that can administer large volumes (up to 50 mL) of viscous biological therapies, which work with biopharmaceutical companies to address key issues of aggregation and viscosity found in monoclonal antibody delivery. This collaboration with pharmaceutical companies provides a means to create scalable solutions to the long-term management of chronic diseases. In addition to Enable Injections, Capsugel Dosage Form Solutions (DFS) also maintains a vertically integrated B2B model. Capsugel collaborates with pharmaceutical and nutritional companies to design encapsulated liquid filling technology through the use of their LIPIDEX platform, providing both rapid and efficient formulations from clinical testing to large-scale production via FDA accredited sites for high containment injectables (i.e., hormones).

Additionally, BD Medical is enhancing the ability to inject beneath the skin through collaborations like its partnership with ten23 health for developing RFID-enabled pre-filled syringes that allow the tracking of products during filling and finishing stages and with Biocorp to create a connected version of the UltraSafe Plus Passive Needle Guard, which will enable the monitoring of patients' use of anticoagulants digitally. The Maggie 5.0 Autoinjector from SHL Medical includes Needle Isolation Technology and is working with oncology-focused pharmaceutical companies to help them customize the gauge used in the delivery system to ensure the best possible timeframes for delivering high doses of Therapeutics. Credence MedSystems offers the Connect system, which allows for remote data logging for prefilled syringes used in clinical studies. Phillips-Medisize is a partner of Bayer on the BETACONNECT platform for treating multiple sclerosis, through which they provide connected auto-injectors that enable a patient's adherence to the treatment by using an app to track the patient's activity. These examples reflect an ecosystem of collaboration between CDMOs and medical device manufacturers who develop each other's platforms together, which allow for smooth integration throughout the various steps required in going from R&D to putting products into distribution, ultimately resulting in increased operational efficiencies within the competitive landscape of the US.

The US Food and Drug Administration, World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization) are among the primary and secondary sources referred to while preparing the injectable drug delivery market report.

Product Code: TIPRE00004204

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. Injectable Drug Delivery Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Force Analysis
2.5 PEST Analysis
2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
- 2.6.1 Import Analysis for Key Countries
- 2.6.2 Export Analysis for Key Countries
2.7 Impact of Artificial Intelligence (AI)
2.8 Product or Technology Roadmap
2.9 Sustainability and ESG Trends
- 2.9.1 Environmental Trends
- 2.9.2 Social Trends
- 2.9.3 Governance Trends
2.10 Regulatory Framework

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Concentration

4. Injectable Drug Delivery Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Global Burden of Chronic Diseases
- 4.1.2 Surge in Biologics and Monoclonal Antibodies Requiring Parenteral Administration
- 4.1.3 Technological Advancements in Self-Injection and Patient-Centric Delivery Devices
4.2 Market Restraints
- 4.2.1 High Costs Associated with Manufacturing and Development
- 4.2.2 Stringent Regulatory Requirements and Protracted Approval Processes
- 4.2.3 Vulnerabilities in Supply Chains
4.3 Market Opportunities
- 4.3.1 Harnessing Long-Acting Injectables
- 4.3.2 Expanding Role of Injectable Immunotherapies in Cancer Treatment
- 4.3.3 Enhancing Mental Health Outcomes
4.4 Future Trends
- 4.4.1 AI-Driven Personalization
- 4.4.2 Advancing Lipid Nanoparticle Injectables for Rapid-Response Vaccines and Gene Editing
- 4.4.3 Biodegradable Polymers and Green Packaging in Injectable Drug Systems
4.5 Impact of Drivers and Restraints

5. Injectable Drug Delivery Market - Global Market Analysis

5.1 Injectable Drug Delivery Market Revenue (US$ Million), 2021-2031
5.2 Injectable Drug Delivery Market Forecast and Analysis

6. Injectable Drug Delivery Market Revenue Analysis -Device Type

6.1 Injectable Drug Delivery Market Forecasts and Analysis by Device Type
- 6.1.1 Conventional Drug Delivery Devices
  - 6.1.1.1 Overview
  - 6.1.1.2 Conventional Drug Delivery Devices: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 6.1.2 Advanced Drug Delivery Devices
  - 6.1.2.1 Overview
  - 6.1.2.2 Advanced Drug Delivery Devices: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

7. Injectable Drug Delivery Market Revenue Analysis -Formulation

7.1 Injectable Drug Delivery Market Forecasts and Analysis by Formulation
- 7.1.1 Conventional Drug Delivery
  - 7.1.1.1 Overview
  - 7.1.1.2 Conventional Drug Delivery: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 7.1.2 Novel Drug Delivery
  - 7.1.2.1 Overview
  - 7.1.2.2 Novel Drug Delivery: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 7.1.3 Long Acting Injectable Formulations
  - 7.1.3.1 Overview

8. Injectable Drug Delivery Market Revenue Analysis -Formulation Packaging

8.1 Injectable Drug Delivery Market Forecasts and Analysis by Formulation Packaging
- 8.1.1 Ampoules
  - 8.1.1.1 Overview
  - 8.1.1.2 Ampoules: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 8.1.2 Vials
  - 8.1.2.1 Overview
  - 8.1.2.2 Vials: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 8.1.3 Cartridges
  - 8.1.3.1 Overview
  - 8.1.3.2 Cartridges: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 8.1.4 Bottles
  - 8.1.4.1 Overview
  - 8.1.4.2 Bottles: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

9. Injectable Drug Delivery Market Revenue Analysis -Therapeutic Application

9.1 Injectable Drug Delivery Market Forecasts and Analysis by Therapeutic Application
- 9.1.1 Diabetes
  - 9.1.1.1 Overview
  - 9.1.1.2 Diabetes: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 9.1.2 Oncology
  - 9.1.2.1 Overview
  - 9.1.2.2 Oncology: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 9.1.3 Auto-Immune Disorders
  - 9.1.3.1 Overview
  - 9.1.3.2 Auto-Immune Disorders: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 9.1.4 Cardiovascular Diseases
  - 9.1.4.1 Overview
  - 9.1.4.2 Cardiovascular Diseases: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 9.1.5 Infectious Diseases
  - 9.1.5.1 Overview
  - 9.1.5.2 Infectious Diseases: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 9.1.6 Pain Management
  - 9.1.6.1 Overview
  - 9.1.6.2 Pain Management: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 9.1.7 Other Therapeutic Application
  - 9.1.7.1 Overview
  - 9.1.7.2 Other Therapeutic Application: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

10. Injectable Drug Delivery Market Revenue Analysis -Route Of Administration

10.1 Injectable Drug Delivery Market Forecasts and Analysis by Route Of Administration
- 10.1.1 Sub-cutaneous
  - 10.1.1.1 Overview
  - 10.1.1.2 Sub-cutaneous: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 10.1.2 Intramuscular
  - 10.1.2.1 Overview
  - 10.1.2.2 Intramuscular: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 10.1.3 Intravenous
  - 10.1.3.1 Overview
  - 10.1.3.2 Intravenous: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 10.1.4 Other Route of Administration
  - 10.1.4.1 Overview
  - 10.1.4.2 Other Route of Administration: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

11. Injectable Drug Delivery Market Revenue Analysis -Usability

11.1 Injectable Drug Delivery Market Forecasts and Analysis by Usability
- 11.1.1 Disposable Injectors
  - 11.1.1.1 Overview
  - 11.1.1.2 Disposable Injectors: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 11.1.2 Re-usable Injectors
  - 11.1.2.1 Overview
  - 11.1.2.2 Re-usable Injectors: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

12. Injectable Drug Delivery Market Revenue Analysis -End User

12.1 Injectable Drug Delivery Market Forecasts and Analysis by End User
- 12.1.1 Pharmaceutical and Biopharma Companies
  - 12.1.1.1 Overview
  - 12.1.1.2 Pharmaceutical and Biopharma Companies: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
- 12.1.2 CMOs and CDMOs
  - 12.1.2.1 Overview
  - 12.1.2.2 CMOs and CDMOs: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

13. Injectable Drug Delivery Market - Geographical Analysis

13.1 North America
- 13.1.1 North America Injectable Drug Delivery Market Overview
- 13.1.2 North America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 13.1.3 North America: Injectable Drug Delivery Market- By Segmentation
  - 13.1.3.1 Device Type
  - 13.1.3.2 Advanced Drug Delivery Devices By Device Type
  - 13.1.3.3 Formulation
  - 13.1.3.4 Conventional Drug Delivery By Formulation
  - 13.1.3.5 Novel Drug Delivery By Formulation
  - 13.1.3.6 Formulation Packaging
  - 13.1.3.7 Therapeutic Application
  - 13.1.3.8 Route Of Administration
  - 13.1.3.9 Usability
  - 13.1.3.10 End User
- 13.1.4 North America: Injectable Drug Delivery Market Breakdown by Countries
  - 13.1.4.1 United States Market
    - 13.1.4.1.1 United States: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.1.4.1.2 United States: Injectable Drug Delivery Market- By Segmentation
      - 13.1.4.1.2.1 Device Type
      - 13.1.4.1.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.1.4.1.2.3 Formulation
      - 13.1.4.1.2.4 Conventional Drug Delivery By Formulation
      - 13.1.4.1.2.5 Novel Drug Delivery By Formulation
      - 13.1.4.1.2.6 Formulation Packaging
      - 13.1.4.1.2.7 Therapeutic Application
      - 13.1.4.1.2.8 Route Of Administration
      - 13.1.4.1.2.9 Usability
      - 13.1.4.1.2.10 End User
  - 13.1.4.2 Canada Market
    - 13.1.4.2.1 Canada: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.1.4.2.2 Canada: Injectable Drug Delivery Market- By Segmentation
      - 13.1.4.2.2.1 Device Type
      - 13.1.4.2.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.1.4.2.2.3 Formulation
      - 13.1.4.2.2.4 Conventional Drug Delivery By Formulation
      - 13.1.4.2.2.5 Novel Drug Delivery By Formulation
      - 13.1.4.2.2.6 Formulation Packaging
      - 13.1.4.2.2.7 Therapeutic Application
      - 13.1.4.2.2.8 Route Of Administration
      - 13.1.4.2.2.9 Usability
      - 13.1.4.2.2.10 End User
  - 13.1.4.3 Mexico Market
    - 13.1.4.3.1 Mexico: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.1.4.3.2 Mexico: Injectable Drug Delivery Market- By Segmentation
      - 13.1.4.3.2.1 Device Type
      - 13.1.4.3.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.1.4.3.2.3 Formulation
      - 13.1.4.3.2.4 Conventional Drug Delivery By Formulation
      - 13.1.4.3.2.5 Novel Drug Delivery By Formulation
      - 13.1.4.3.2.6 Formulation Packaging
      - 13.1.4.3.2.7 Therapeutic Application
      - 13.1.4.3.2.8 Route Of Administration
      - 13.1.4.3.2.9 Usability
      - 13.1.4.3.2.10 End User
13.2 Europe
- 13.2.1 Europe Injectable Drug Delivery Market Overview
- 13.2.2 Europe: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 13.2.3 Europe: Injectable Drug Delivery Market- By Segmentation
  - 13.2.3.1 Device Type
  - 13.2.3.2 Advanced Drug Delivery Devices By Device Type
  - 13.2.3.3 Formulation
  - 13.2.3.4 Conventional Drug Delivery By Formulation
  - 13.2.3.5 Novel Drug Delivery By Formulation
  - 13.2.3.6 Formulation Packaging
  - 13.2.3.7 Therapeutic Application
  - 13.2.3.8 Route Of Administration
  - 13.2.3.9 Usability
  - 13.2.3.10 End User
- 13.2.4 Europe: Injectable Drug Delivery Market Breakdown by Countries
  - 13.2.4.1 Germany Market
    - 13.2.4.1.1 Germany: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.2.4.1.2 Germany: Injectable Drug Delivery Market- By Segmentation
      - 13.2.4.1.2.1 Device Type
      - 13.2.4.1.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.2.4.1.2.3 Formulation
      - 13.2.4.1.2.4 Conventional Drug Delivery By Formulation
      - 13.2.4.1.2.5 Novel Drug Delivery By Formulation
      - 13.2.4.1.2.6 Formulation Packaging
      - 13.2.4.1.2.7 Therapeutic Application
      - 13.2.4.1.2.8 Route Of Administration
      - 13.2.4.1.2.9 Usability
      - 13.2.4.1.2.10 End User
  - 13.2.4.2 United Kingdom Market
    - 13.2.4.2.1 United Kingdom: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.2.4.2.2 United Kingdom: Injectable Drug Delivery Market- By Segmentation
      - 13.2.4.2.2.1 Device Type
      - 13.2.4.2.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.2.4.2.2.3 Formulation
      - 13.2.4.2.2.4 Conventional Drug Delivery By Formulation
      - 13.2.4.2.2.5 Novel Drug Delivery By Formulation
      - 13.2.4.2.2.6 Formulation Packaging
      - 13.2.4.2.2.7 Therapeutic Application
      - 13.2.4.2.2.8 Route Of Administration
      - 13.2.4.2.2.9 Usability
      - 13.2.4.2.2.10 End User
  - 13.2.4.3 France Market
    - 13.2.4.3.1 France: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.2.4.3.2 France: Injectable Drug Delivery Market- By Segmentation
      - 13.2.4.3.2.1 Device Type
      - 13.2.4.3.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.2.4.3.2.3 Formulation
      - 13.2.4.3.2.4 Conventional Drug Delivery By Formulation
      - 13.2.4.3.2.5 Novel Drug Delivery By Formulation
      - 13.2.4.3.2.6 Formulation Packaging
      - 13.2.4.3.2.7 Therapeutic Application
      - 13.2.4.3.2.8 Route Of Administration
      - 13.2.4.3.2.9 Usability
      - 13.2.4.3.2.10 End User
  - 13.2.4.4 Spain Market
    - 13.2.4.4.1 Spain: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.2.4.4.2 Spain: Injectable Drug Delivery Market- By Segmentation
      - 13.2.4.4.2.1 Device Type
      - 13.2.4.4.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.2.4.4.2.3 Formulation
      - 13.2.4.4.2.4 Conventional Drug Delivery By Formulation
      - 13.2.4.4.2.5 Novel Drug Delivery By Formulation
      - 13.2.4.4.2.6 Formulation Packaging
      - 13.2.4.4.2.7 Therapeutic Application
      - 13.2.4.4.2.8 Route Of Administration
      - 13.2.4.4.2.9 Usability
      - 13.2.4.4.2.10 End User
  - 13.2.4.5 Italy Market
    - 13.2.4.5.1 Italy: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.2.4.5.2 Italy: Injectable Drug Delivery Market- By Segmentation
      - 13.2.4.5.2.1 Device Type
      - 13.2.4.5.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.2.4.5.2.3 Formulation
      - 13.2.4.5.2.4 Conventional Drug Delivery By Formulation
      - 13.2.4.5.2.5 Novel Drug Delivery By Formulation
      - 13.2.4.5.2.6 Formulation Packaging
      - 13.2.4.5.2.7 Therapeutic Application
      - 13.2.4.5.2.8 Route Of Administration
      - 13.2.4.5.2.9 Usability
      - 13.2.4.5.2.10 End User
  - 13.2.4.6 Rest of Europe Market
    - 13.2.4.6.1 Rest of Europe: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.2.4.6.2 Rest of Europe: Injectable Drug Delivery Market- By Segmentation
      - 13.2.4.6.2.1 Device Type
      - 13.2.4.6.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.2.4.6.2.3 Formulation
      - 13.2.4.6.2.4 Conventional Drug Delivery By Formulation
      - 13.2.4.6.2.5 Novel Drug Delivery By Formulation
      - 13.2.4.6.2.6 Formulation Packaging
      - 13.2.4.6.2.7 Therapeutic Application
      - 13.2.4.6.2.8 Route Of Administration
      - 13.2.4.6.2.9 Usability
      - 13.2.4.6.2.10 End User
13.3 Asia Pacific
- 13.3.1 Asia Pacific Injectable Drug Delivery Market Overview
- 13.3.2 Asia Pacific: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 13.3.3 Asia Pacific: Injectable Drug Delivery Market- By Segmentation
  - 13.3.3.1 Device Type
  - 13.3.3.2 Advanced Drug Delivery Devices By Device Type
  - 13.3.3.3 Formulation
  - 13.3.3.4 Conventional Drug Delivery By Formulation
  - 13.3.3.5 Novel Drug Delivery By Formulation
  - 13.3.3.6 Formulation Packaging
  - 13.3.3.7 Therapeutic Application
  - 13.3.3.8 Route Of Administration
  - 13.3.3.9 Usability
  - 13.3.3.10 End User
- 13.3.4 Asia Pacific: Injectable Drug Delivery Market Breakdown by Countries
  - 13.3.4.1 China Market
    - 13.3.4.1.1 China: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.3.4.1.2 China: Injectable Drug Delivery Market- By Segmentation
      - 13.3.4.1.2.1 Device Type
      - 13.3.4.1.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.3.4.1.2.3 Formulation
      - 13.3.4.1.2.4 Conventional Drug Delivery By Formulation
      - 13.3.4.1.2.5 Novel Drug Delivery By Formulation
      - 13.3.4.1.2.6 Formulation Packaging
      - 13.3.4.1.2.7 Therapeutic Application
      - 13.3.4.1.2.8 Route Of Administration
      - 13.3.4.1.2.9 Usability
      - 13.3.4.1.2.10 End User
  - 13.3.4.2 Japan Market
    - 13.3.4.2.1 Japan: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.3.4.2.2 Japan: Injectable Drug Delivery Market- By Segmentation
      - 13.3.4.2.2.1 Device Type
      - 13.3.4.2.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.3.4.2.2.3 Formulation
      - 13.3.4.2.2.4 Conventional Drug Delivery By Formulation
      - 13.3.4.2.2.5 Novel Drug Delivery By Formulation
      - 13.3.4.2.2.6 Formulation Packaging
      - 13.3.4.2.2.7 Therapeutic Application
      - 13.3.4.2.2.8 Route Of Administration
      - 13.3.4.2.2.9 Usability
      - 13.3.4.2.2.10 End User
  - 13.3.4.3 India Market
    - 13.3.4.3.1 India: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.3.4.3.2 India: Injectable Drug Delivery Market- By Segmentation
      - 13.3.4.3.2.1 Device Type
      - 13.3.4.3.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.3.4.3.2.3 Formulation
      - 13.3.4.3.2.4 Conventional Drug Delivery By Formulation
      - 13.3.4.3.2.5 Novel Drug Delivery By Formulation
      - 13.3.4.3.2.6 Formulation Packaging
      - 13.3.4.3.2.7 Therapeutic Application
      - 13.3.4.3.2.8 Route Of Administration
      - 13.3.4.3.2.9 Usability
      - 13.3.4.3.2.10 End User
  - 13.3.4.4 Australia Market
    - 13.3.4.4.1 Australia: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.3.4.4.2 Australia: Injectable Drug Delivery Market- By Segmentation
      - 13.3.4.4.2.1 Device Type
      - 13.3.4.4.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.3.4.4.2.3 Formulation
      - 13.3.4.4.2.4 Conventional Drug Delivery By Formulation
      - 13.3.4.4.2.5 Novel Drug Delivery By Formulation
      - 13.3.4.4.2.6 Formulation Packaging
      - 13.3.4.4.2.7 Therapeutic Application
      - 13.3.4.4.2.8 Route Of Administration
      - 13.3.4.4.2.9 Usability
      - 13.3.4.4.2.10 End User
  - 13.3.4.5 South Korea Market
    - 13.3.4.5.1 South Korea: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.3.4.5.2 South Korea: Injectable Drug Delivery Market- By Segmentation
      - 13.3.4.5.2.1 Device Type
      - 13.3.4.5.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.3.4.5.2.3 Formulation
      - 13.3.4.5.2.4 Conventional Drug Delivery By Formulation
      - 13.3.4.5.2.5 Novel Drug Delivery By Formulation
      - 13.3.4.5.2.6 Formulation Packaging
      - 13.3.4.5.2.7 Therapeutic Application
      - 13.3.4.5.2.8 Route Of Administration
      - 13.3.4.5.2.9 Usability
      - 13.3.4.5.2.10 End User
  - 13.3.4.6 Rest of APAC Market
    - 13.3.4.6.1 Rest of APAC: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.3.4.6.2 Rest of APAC: Injectable Drug Delivery Market- By Segmentation
      - 13.3.4.6.2.1 Device Type
      - 13.3.4.6.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.3.4.6.2.3 Formulation
      - 13.3.4.6.2.4 Conventional Drug Delivery By Formulation
      - 13.3.4.6.2.5 Novel Drug Delivery By Formulation
      - 13.3.4.6.2.6 Formulation Packaging
      - 13.3.4.6.2.7 Therapeutic Application
      - 13.3.4.6.2.8 Route Of Administration
      - 13.3.4.6.2.9 Usability
      - 13.3.4.6.2.10 End User
13.4 Middle East and Africa
- 13.4.1 Middle East and Africa Injectable Drug Delivery Market Overview
- 13.4.2 Middle East and Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 13.4.3 Middle East and Africa: Injectable Drug Delivery Market- By Segmentation
  - 13.4.3.1 Device Type
  - 13.4.3.2 Advanced Drug Delivery Devices By Device Type
  - 13.4.3.3 Formulation
  - 13.4.3.4 Conventional Drug Delivery By Formulation
  - 13.4.3.5 Novel Drug Delivery By Formulation
  - 13.4.3.6 Formulation Packaging
  - 13.4.3.7 Therapeutic Application
  - 13.4.3.8 Route Of Administration
  - 13.4.3.9 Usability
  - 13.4.3.10 End User
- 13.4.4 Middle East and Africa: Injectable Drug Delivery Market Breakdown by Countries
  - 13.4.4.1 Saudi Arabia Market
    - 13.4.4.1.1 Saudi Arabia: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.4.4.1.2 Saudi Arabia: Injectable Drug Delivery Market- By Segmentation
      - 13.4.4.1.2.1 Device Type
      - 13.4.4.1.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.4.4.1.2.3 Formulation
      - 13.4.4.1.2.4 Conventional Drug Delivery By Formulation
      - 13.4.4.1.2.5 Novel Drug Delivery By Formulation
      - 13.4.4.1.2.6 Formulation Packaging
      - 13.4.4.1.2.7 Therapeutic Application
      - 13.4.4.1.2.8 Route Of Administration
      - 13.4.4.1.2.9 Usability
      - 13.4.4.1.2.10 End User
  - 13.4.4.2 South Africa Market
    - 13.4.4.2.1 South Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.4.4.2.2 South Africa: Injectable Drug Delivery Market- By Segmentation
      - 13.4.4.2.2.1 Device Type
      - 13.4.4.2.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.4.4.2.2.3 Formulation
      - 13.4.4.2.2.4 Conventional Drug Delivery By Formulation
      - 13.4.4.2.2.5 Novel Drug Delivery By Formulation
      - 13.4.4.2.2.6 Formulation Packaging
      - 13.4.4.2.2.7 Therapeutic Application
      - 13.4.4.2.2.8 Route Of Administration
      - 13.4.4.2.2.9 Usability
      - 13.4.4.2.2.10 End User
  - 13.4.4.3 United Arab Emirates Market
    - 13.4.4.3.1 United Arab Emirates: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.4.4.3.2 United Arab Emirates: Injectable Drug Delivery Market- By Segmentation
      - 13.4.4.3.2.1 Device Type
      - 13.4.4.3.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.4.4.3.2.3 Formulation
      - 13.4.4.3.2.4 Conventional Drug Delivery By Formulation
      - 13.4.4.3.2.5 Novel Drug Delivery By Formulation
      - 13.4.4.3.2.6 Formulation Packaging
      - 13.4.4.3.2.7 Therapeutic Application
      - 13.4.4.3.2.8 Route Of Administration
      - 13.4.4.3.2.9 Usability
      - 13.4.4.3.2.10 End User
  - 13.4.4.4 Rest of Middle East and Africa Market
    - 13.4.4.4.1 Rest of Middle East and Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.4.4.4.2 Rest of Middle East and Africa: Injectable Drug Delivery Market- By Segmentation
      - 13.4.4.4.2.1 Device Type
      - 13.4.4.4.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.4.4.4.2.3 Formulation
      - 13.4.4.4.2.4 Conventional Drug Delivery By Formulation
      - 13.4.4.4.2.5 Novel Drug Delivery By Formulation
      - 13.4.4.4.2.6 Formulation Packaging
      - 13.4.4.4.2.7 Therapeutic Application
      - 13.4.4.4.2.8 Route Of Administration
      - 13.4.4.4.2.9 Usability
      - 13.4.4.4.2.10 End User
13.5 South and Central America
- 13.5.1 South and Central America Injectable Drug Delivery Market Overview
- 13.5.2 South and Central America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 13.5.3 South and Central America: Injectable Drug Delivery Market- By Segmentation
  - 13.5.3.1 Device Type
  - 13.5.3.2 Advanced Drug Delivery Devices By Device Type
  - 13.5.3.3 Formulation
  - 13.5.3.4 Conventional Drug Delivery By Formulation
  - 13.5.3.5 Novel Drug Delivery By Formulation
  - 13.5.3.6 Formulation Packaging
  - 13.5.3.7 Therapeutic Application
  - 13.5.3.8 Route Of Administration
  - 13.5.3.9 Usability
  - 13.5.3.10 End User
- 13.5.4 South and Central America: Injectable Drug Delivery Market Breakdown by Countries
  - 13.5.4.1 Brazil Market
    - 13.5.4.1.1 Brazil: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.5.4.1.2 Brazil: Injectable Drug Delivery Market- By Segmentation
      - 13.5.4.1.2.1 Device Type
      - 13.5.4.1.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.5.4.1.2.3 Formulation
      - 13.5.4.1.2.4 Conventional Drug Delivery By Formulation
      - 13.5.4.1.2.5 Novel Drug Delivery By Formulation
      - 13.5.4.1.2.6 Formulation Packaging
      - 13.5.4.1.2.7 Therapeutic Application
      - 13.5.4.1.2.8 Route Of Administration
      - 13.5.4.1.2.9 Usability
      - 13.5.4.1.2.10 End User
  - 13.5.4.2 Argentina Market
    - 13.5.4.2.1 Argentina: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.5.4.2.2 Argentina: Injectable Drug Delivery Market- By Segmentation
      - 13.5.4.2.2.1 Device Type
      - 13.5.4.2.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.5.4.2.2.3 Formulation
      - 13.5.4.2.2.4 Conventional Drug Delivery By Formulation
      - 13.5.4.2.2.5 Novel Drug Delivery By Formulation
      - 13.5.4.2.2.6 Formulation Packaging
      - 13.5.4.2.2.7 Therapeutic Application
      - 13.5.4.2.2.8 Route Of Administration
      - 13.5.4.2.2.9 Usability
      - 13.5.4.2.2.10 End User
  - 13.5.4.3 Rest of South and Central America Market
    - 13.5.4.3.1 Rest of South and Central America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 13.5.4.3.2 Rest of South and Central America: Injectable Drug Delivery Market- By Segmentation
      - 13.5.4.3.2.1 Device Type
      - 13.5.4.3.2.2 Advanced Drug Delivery Devices By Device Type
      - 13.5.4.3.2.3 Formulation
      - 13.5.4.3.2.4 Conventional Drug Delivery By Formulation
      - 13.5.4.3.2.5 Novel Drug Delivery By Formulation
      - 13.5.4.3.2.6 Formulation Packaging
      - 13.5.4.3.2.7 Therapeutic Application
      - 13.5.4.3.2.8 Route Of Administration
      - 13.5.4.3.2.9 Usability
      - 13.5.4.3.2.10 End User

14. Injectable Drug Delivery Market Industry Landscape

15. Injectable Drug Delivery Market - Key Company Profiles

15.1 Cardinal Health Inc
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 Becton Dickinson and Co
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 Schott AG
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 B Braun SE
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
15.5 Terumo Corp
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 Phillips-Medisize
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 Nipro Corp
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
15.8 Gerresheimer AG
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
15.9 Kindeva Drug Delivery LP
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
15.10 West Pharmaceutical Services Inc
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments

16. List of Additional Companies Analyzed

16.1 List of Additional Companies Analyzed

17. Appendix

17.1 Glossary
17.2 Research Methodology and Approach
- 17.2.1 Secondary Research
- 17.2.2 Primary Research
- 17.2.3 Market Estimation Approach
  - 17.2.3.1 Supply Side Analysis
  - 17.2.3.2 Demand Side Analysis
- 17.2.4 Research Assumptions and Limitations
- 17.2.5 Currency Conversion
17.3 About The Insight Partners
17.4 Market Intelligence Cloud